Contribution of Regulatory T Cell Methylation Modifications to the Pathogenesis of Allergic Airway Diseases | Zendy

Jiani Li | Zendy; Jichao Sha | Zendy; Liwei Sun | Zendy; Dongdong Zhu | Zendy; Cuida Meng | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Contribution of Regulatory T Cell Methylation Modifications to the Pathogenesis of Allergic Airway Diseases

Author(s) -

Jiani Li,

Jichao Sha,

Liwei Sun,

Dongdong Zhu,

Cuida Meng

Publication year - 2021

Publication title -

journal of immunology research

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.315

H-Index - 83

eISSN - 2314-8861

pISSN - 2314-7156

DOI - 10.1155/2021/5590217

Subject(s) - epigenetics , immunology , pathogenesis , immune system , foxp3 , allergy , autoimmunity , dna methylation , transcription factor , regulatory t cell , methylation , biology , immune tolerance , t cell , medicine , gene , genetics , il 2 receptor , gene expression

Regulatory T (Treg) cells are a subtype of CD4 + T cells that play a significant role in the protection from autoimmunity and the maintenance of immune tolerance via immune regulation. Epigenetic modifications of Treg cells (i.e., cytosine methylation at the promoter region of the transcription factor, Forkhead Box P3) have been found to be closely associated with allergic diseases, including allergic rhinitis, asthma, and food allergies. In this study, we highlighted the recent evidence on the contribution of epigenetic modifications in Treg cells to the pathogenesis of allergic diseases. Moreover, we also discussed directions for future clinical treatment approaches, with a particular emphasis on Treg cell-targeted therapies for allergic disorders.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research